TIRZEPATIDE 40mg

Peptide: Tirzepatide 5mg
Tirzepatide 5mg is a lower-fill research presentation of a dual GIP/GLP-1 receptor agonist peptide. It is studied for incretin biology, pancreatic signaling, glycemic regulation, and energy-balance pathways. It is not intended for human or veterinary use outside approved clinical settings.

Research Applications
Incretin Pathway Research
Used to investigate GIP and GLP-1 receptor co-agonism.
Sources: https://pubmed.ncbi.nlm.nih.gov/36050763/

Pancreatic Signaling Studies
Applied in research exploring insulin secretion and beta-cell response pathways.
Sources: https://pubmed.ncbi.nlm.nih.gov/32730231/

Weight & Appetite Models
Used to study appetite regulation, gastric-emptying-related signaling, and body-weight outcomes.
Sources: https://pubmed.ncbi.nlm.nih.gov/36050763/